Allen Institute is a Seattle-based nonprofit biomedical research institute and strategic capital allocator with direct startup investment activity in the United States. It is most relevant to founders in life sciences and deep-tech bioscience, including biotechnology, neuroscience, cell science, immunology, AI-enabled bioscience, health technology, data, and big-data research tools. The institute is better suited for companies aligned with scientific research and strategic partnerships than for founders seeking a conventional sector-agnostic venture capital fund.